Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STAAR SURGICAL COSTAA · Entity 4851 | President and CEO | August 14, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STAAR SURGICAL CO
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,887 |
Reported balance
After 2026-08-14 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-08-14 · Exercise / conversion · Acquired 7,331 · Balance 93,887 |
| Common StockSEC Table I · non-derivative | Direct | 97,617 |
Reported balance
After 2026-08-14 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2026-08-14 · Tax withholding · Disposed 3,730 · Balance 97,617 F1: On August 14, 2026, the third tranche of 7,331 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with his annual equity grant vested, of which 3,730 shares were withheld to satisfy taxes. |
| Common StockSEC Table I · non-derivative | Direct | 93,951 |
Reported balance
After 2026-08-14 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2026-08-14 · Exercise / conversion · Acquired 3,666 · Balance 93,951 |
| Common StockSEC Table I · non-derivative | Direct | 95,816 |
Reported balance
After 2026-08-14 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2026-08-14 · Tax withholding · Disposed 1,865 · Balance 95,816 F2: On August 14, 2026, the third tranche of 3,666 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with his expanded role as President and Chief Operating Officer vested, of which 1,865 shares were withheld to satisfy taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 22,493 |
Reported balance
After 2026-08-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-14 · Grant · Acquired 22,493 · Balance 22,493 F3: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F4: The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to 1/3 on the first anniversary of the Grant Date, and the remaining 2/3 vesting in 24 substantially equal monthly installments thereafter. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.18 · Expires 2036-08-13 | Direct | 40,471 |
Reported balance
After 2026-08-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-14 · Grant · Acquired 40,471 · Balance 40,471 F5: The Reporting Person was granted an option to purchase 40,471 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.18 · Expires 2036-08-13 | Direct | 37,962 |
Reported balance
After 2026-08-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-14 · Grant · Acquired 37,962 · Balance 37,962 F6: The Reporting Person was granted an option to purchase 37,962 shares of Company common stock. The shares underlying the option vest over 42 months from the Grant Date, with one-third vesting on the 18-month anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. |
| Performance Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.18 · Expires 2036-08-13 | Direct | 131,830 |
Reported balance
After 2026-08-14 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-14 · Grant · Acquired 131,830 · Balance 131,830 F7: The Reporting Person was granted a performance option to purchase 131,830 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the first anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. |
| Performance Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.18 · Expires 2036-08-13 | Direct | 123,659 |
Reported balance
After 2026-08-14 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-14 · Grant · Acquired 123,659 · Balance 123,659 F8: The Reporting Person was granted a performance option to purchase 123,659 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the 18-month anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-12-31 | Direct | 93,887 |
Reported balance
After 2026-08-14 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-08-14 · Exercise / conversion · Acquired 7,331 · Balance 93,887 F9: Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-12-31 | Direct | 97,553 |
Reported balance
After 2026-08-14 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-08-14 · Exercise / conversion · Acquired 3,666 · Balance 97,553 F10: Represents the settlement of the third tranche of PSUs awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 14, 2026, the third tranche of 7,331 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with his annual equity grant vested, of which 3,730 shares were withheld to satisfy taxes.
F2: On August 14, 2026, the third tranche of 3,666 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with his expanded role as President and Chief Operating Officer vested, of which 1,865 shares were withheld to satisfy taxes.
F3: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.
F4: The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to 1/3 on the first anniversary of the Grant Date, and the remaining 2/3 vesting in 24 substantially equal monthly installments thereafter.
F5: The Reporting Person was granted an option to purchase 40,471 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter
F6: The Reporting Person was granted an option to purchase 37,962 shares of Company common stock. The shares underlying the option vest over 42 months from the Grant Date, with one-third vesting on the 18-month anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
F7: The Reporting Person was granted a performance option to purchase 131,830 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the first anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
F8: The Reporting Person was granted a performance option to purchase 123,659 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the 18-month anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
F9: Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
F10: Represents the settlement of the third tranche of PSUs awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 3,666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · derivative · entry 11 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,553 Underlying: Common Stock · 3,666 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Represents the settlement of the third tranche of PSUs awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 7,331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · derivative · entry 10 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,887 Underlying: Common Stock · 7,331 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantPerformance Stock Option (right to buy) · Derivative | 123,659 | $0.00 Strike: $26.18 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · derivative · entry 9 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,659 Underlying: Common Stock · 123,659 shares Expires 2036-08-13 F8 · derivative.exercise_date: The Reporting Person was granted a performance option to purchase 123,659 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the 18-month anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantPerformance Stock Option (right to buy) · Derivative | 131,830 | $0.00 Strike: $26.18 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · derivative · entry 8 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,830 Underlying: Common Stock · 131,830 shares Expires 2036-08-13 F7 · derivative.exercise_date: The Reporting Person was granted a performance option to purchase 131,830 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the first anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantStock Option (right to buy) · Derivative | 37,962 | $0.00 Strike: $26.18 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · derivative · entry 7 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,962 Underlying: Common Stock · 37,962 shares Expires 2036-08-13 F6 · derivative.exercise_date: The Reporting Person was granted an option to purchase 37,962 shares of Company common stock. The shares underlying the option vest over 42 months from the Grant Date, with one-third vesting on the 18-month anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantStock Option (right to buy) · Derivative | 40,471 | $0.00 Strike: $26.18 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · derivative · entry 6 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,471 Underlying: Common Stock · 40,471 shares Expires 2036-08-13 F5 · derivative.exercise_date: The Reporting Person was granted an option to purchase 40,471 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 22,493 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · derivative · entry 5 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,493 Underlying: Common Stock · 22,493 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F4 · derivative.exercise_date: The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to 1/3 on the first anniversary of the Grant Date, and the remaining 2/3 vesting in 24 substantially equal monthly installments thereafter. F4 · derivative.expiration_date: The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to 1/3 on the first anniversary of the Grant Date, and the remaining 2/3 vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,865 | $26.18 | $48,825.70 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · nonDerivative · entry 4 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,816 F2 · shares: On August 14, 2026, the third tranche of 3,666 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with his expanded role as President and Chief Operating Officer vested, of which 1,865 shares were withheld to satisfy taxes. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 3,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · nonDerivative · entry 3 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 3,730 | $26.18 | $97,651.40 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · nonDerivative · entry 2 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,617 F1 · shares: On August 14, 2026, the third tranche of 7,331 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with his annual equity grant vested, of which 3,730 shares were withheld to satisfy taxes. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 7,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000014 · ownership.xml · nonDerivative · entry 1 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 20,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000012 · ownership.xml · derivative · entry 3 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer of the Issuer on such date. These RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer of the Issuer on such date. These RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer of the Issuer on such date. These RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 10,576 | $24.36 | $257,631.36 |
DisclosureSEC source: 0001970778-26-000012 · ownership.xml · nonDerivative · entry 2 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,556 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 20,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001970778-26-000012 · ownership.xml · nonDerivative · entry 1 Foust Warren · CIK 0001970778 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer of the Issuer on such date. These RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. F1 · price: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer of the Issuer on such date. These RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. F2 · balance_after: Due to clerical errors, the Reporting Person's prior Form 4 filed with the Securities and Exchange Commission on May 19, 2026, incorrectly reported this value as 83,112 when the Reporting Person beneficially owned 76,345 shares. The values have been corrected herein. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 3,666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · derivative · entry 12 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,990 Underlying: Common Stock · 3,666 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Represents the settlement of the second tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 7,331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · derivative · entry 11 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,324 Underlying: Common Stock · 7,331 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Represents the settlement of the first tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 7,331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · derivative · entry 10 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,993 Underlying: Common Stock · 7,331 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 14,662 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · derivative · entry 9 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,662 Underlying: Common Stock · 14,662 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,865 | $32.07 | $59,810.55 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · nonDerivative · entry 8 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,112 F4 · shares: On May 15, 2026, the second tranche of 3,666 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his expanded role as President & Chief Operating Officer vested, of which 1,865 shares were withheld to satisfy taxes. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 3,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · nonDerivative · entry 7 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,987 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 3,730 | $32.07 | $119,621.10 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · nonDerivative · entry 6 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,321 F3 · shares: On May 15, 2026, the first tranche of 7,331 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his expanded role as President & Chief Operating Officer vested, of which 3,730 shares were withheld to satisfy taxes. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 7,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · nonDerivative · entry 5 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,051 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 3,730 | $32.07 | $119,621.10 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · nonDerivative · entry 4 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,720 F2 · shares: On May 15, 2026, the second tranche of 7,331 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his annual equity grant vested, of which 3,730 shares were withheld to satisfy taxes. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 7,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · nonDerivative · entry 3 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,450 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 7,460 | $32.07 | $239,242.20 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · nonDerivative · entry 2 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,119 F1 · shares: On May 15, 2026, the first tranche of 14,662 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with his annual equity grant vested, of which 7,460 shares were withheld to satisfy taxes . Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 14,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000009 · ownership.xml · nonDerivative · entry 1 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,579 Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 3,448 | $26.69 | $92,027.12 |
DisclosureSEC source: 0001970778-26-000007 · ownership.xml · nonDerivative · entry 1 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,917 F1 · security: Reflects restricted stock units granted to the Reporting Person on May 8, 2023. These RSUs vested as to 1/3 (6,777 shares) on May 8, 2024, 1/3 (6,777 shares) on May 8, 2025, and 1/3 (6,777 shares) on May 8, 2026. On May 8, 2026, 3,448 shares were withheld to satisfy taxes. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 9,775 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000003 · ownership.xml · derivative · entry 7 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,551 Underlying: Common Stock · 9,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F4 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (9,775 shares) on March 14, 2026, and will vest as to 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028. F4 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (9,775 shares) on March 14, 2026, and will vest as to 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 19,550 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000003 · ownership.xml · derivative · entry 6 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,101 Underlying: Common Stock · 19,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F3 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (19,550 shares) on March 14, 2026, and will vest as to 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028. F3 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (19,550 shares) on March 14, 2026, and will vest as to 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 9,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000003 · ownership.xml · nonDerivative · entry 3 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (9,775 shares) on March 14, 2026, and will vest as to 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028. F5 · balance_after: Includes previously granted RSUs, which are subject to future vesting. Read SEC document |
| March 14, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 19,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000003 · ownership.xml · nonDerivative · entry 2 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (19,550 shares) on March 14, 2026, and will vest as to 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028. Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 45,117 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000003 · ownership.xml · derivative · entry 5 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,117 Underlying: Common Stock · 45,117 shares Expires not disclosed F6 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (15,039 shares) on March 13, 2027, 1/3 (15,039 shares) on March 13, 2028, and 1/3 (15,039 shares) on March 13, 2029. F2 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (15,039 shares) on March 13, 2027, 1/3 (15,039 shares) on March 13, 2028, and 1/3 (15,039 shares) on March 13, 2029. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 8,175 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000003 · ownership.xml · derivative · entry 4 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,175 Underlying: Common Stock · 8,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and will vest as to 1/3 (8,175 shares) on March 12, 2027. F1 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and will vest as to 1/3 (8,175 shares) on March 12, 2027. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 8,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001970778-26-000003 · ownership.xml · nonDerivative · entry 1 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and will vest as to 1/3 (8,175 shares) on March 12, 2027. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 22:29 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 20,787 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-037868 · ownership.xml · derivative · entry 1 Foust Warren · CIK 0001970778 · Interim Co-CEO and Pres. & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,787 Underlying: Common Stock · 20,787 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Award of RSUs granted to the Reporting Person on February 2, 2026. These RSUs will vest as to 100% of the shares subject thereto on August 1, 2026. F2 · derivative.expiration_date: Award of RSUs granted to the Reporting Person on February 2, 2026. These RSUs will vest as to 100% of the shares subject thereto on August 1, 2026. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:04 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 29,326 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-041518 · ownership.xml · derivative · entry 2 Foust Warren · CIK 0001970778 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,326 Underlying: Common Stock · 29,326 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F3 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to President and Chief Operating Officer. These RSUs vest as to 1/3 (9,775 shares) on March 14, 2026, 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028. F3 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to President and Chief Operating Officer. These RSUs vest as to 1/3 (9,775 shares) on March 14, 2026, 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:04 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 58,651 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-041518 · ownership.xml · derivative · entry 1 Foust Warren · CIK 0001970778 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,651 Underlying: Common Stock · 58,651 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (19,550 shares) on March 14, 2026, 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028. F2 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (19,550 shares) on March 14, 2026, 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:24 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 8,175 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039707 · ownership.xml · derivative · entry 2 Foust Warren · CIK 0001970778 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,350 Underlying: Common Stock · 8,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, and will vest as 1/3 (8,175 shares) on March 12, 2026, and 1/3 (8,175 shares) on March 12, 2027. F1 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, and will vest as 1/3 (8,175 shares) on March 12, 2026, and 1/3 (8,175 shares) on March 12, 2027. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 23:24 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 8,175 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039707 · ownership.xml · nonDerivative · entry 1 Foust Warren · CIK 0001970778 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (8,175 shares) on March 12, 2025, and will vest as 1/3 (8,175 shares) on March 12, 2026, and 1/3 (8,175 shares) on March 12, 2027. F2 · balance_after: Includes previously granted RSUs, which are subject to future vesting. Read SEC document |
| May 08, 2024 Filed May 9, 2024 21:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 2,418 | $41.02 | $99,186.36 |
DisclosureSEC source: 0000950170-24-057245 · ownership.xml · nonDerivative · entry 1 Foust Warren · CIK 0001970778 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,913 F1 · security: On May 8, 2023, the reporting person was granted an award of 20,331 restricted stock units (RSUs), subject to vesting as to 1/3 of the shares of common stock subject to such RSUs annually over three years. On May 8, 2024, the RSUs vested as to 6,777 shares, and 2,418 shares were withheld to satisfy taxes. F2 · balance_after: Includes shares of common stock owned outright and shares of common stock subject to unvested RSUs. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:19 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 21,966 | $0.00 Strike: $37.64 | $0.00 |
DisclosureSEC source: 0000950170-24-031670 · ownership.xml · derivative · entry 2 Foust Warren · CIK 0001970778 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,996 Underlying: Common Stock · 21,966 shares Expires 2034-03-11 F3 · derivative.exercise_date: Stock options granted to the Reporting Person on March 12, 2024. Options will vest and become exercisable as to 1/3 (7,322 shares) on March 12, 2025, with the remaining 2/3 (14,644 shares) vesting and becoming exercisable monthly over the following 24 months in equal amounts on a monthly basis. In the event such amount does not evenly divide into 24 months, the remaining balance of options will vest and become exercisable on March 12, 2027. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:19 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 24,525 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-031670 · ownership.xml · derivative · entry 1 Foust Warren · CIK 0001970778 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,525 Underlying: Common Stock · 24,525 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and 1/3 (8,175 shares) on March 12, 2027. F2 · derivative.expiration_date: RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and 1/3 (8,175 shares) on March 12, 2027. Read SEC document |
| May 08, 2023 Filed May 9, 2023 21:24 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 37,567 | $0.00 Strike: $67.63 | $0.00 |
DisclosureSEC source: 0001209191-23-028340 · doc4.xml · derivative · entry 2 Foust Warren · CIK 0001970778 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,567 Underlying: Common Stock · 37,567 shares Expires 2033-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The options granted become exercisable as follows: 1/3 on 5/08/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 5/08/2026. Read SEC document |
| May 08, 2023 Filed May 9, 2023 21:24 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 20,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028340 · doc4.xml · nonDerivative · entry 1 Foust Warren · CIK 0001970778 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Award of 20,331 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the shares (6777) on 5/08/24, 1/3 of the shares (6777) on 5/08/25, and 1/3 of the shares (6777) on 5/08/26. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.